Hanadi Al Hamoui

Hanadi Al Hamoui is a Partner at Perella Weinberg. Based in London, she focuses on advising clients in the Consumer & Retail sector across EMEA.

Ms. Al Hamoui brings over 15 years of investment banking experience advising companies on strategic and corporate finance matters.

Notable Transactions in Beauty: L’Oréal’s acquisition of Medik8; the sale of a minority stake in Amouage to L’Oréal; the sale of KIKO Milano to L Catterton (€1.4 billion); PUIG’s initial public offering (€2.7 billion); Galderma’s initial public offering (CHF2.3 billion); the sale of Galderma to EQT; the acquisition of Coppertone by Beiersdorf ($550 million); Nestlé Skin Health’s joint venture with Guthy Renker (Proactiv); Nestlé Skin Health’s acquisition of select aesthetics assets from Valeant ($1.4 billion).

Notable Transactions in Consumer Health: the sale of a 50% controlling stake in Opella (Sanofi Consumer Health) to CD&R (€16 billion); the demerger of Haleon (GSK Consumer) out of GSK (£39 billion); the acquisition of Aimmune Therapeutics by Nestlé ($2.6 billion).

Notable Transactions in Food: the acquisition of Nestlé’s US Confectionery business by Ferrero ($2.8 billion); the acquisition of ADM’s chocolate business by Cargill ($440 million); Eurazeo’s acquisition of European confectionery brands from Mondelēz; the sale of Nestlé’s Davigel to Brakes Group; the sale of Nestlé’s Powerbar and Musashi to Post Holding ($150 million); and the sale of Foodcorp to Rainbow Chicken ($750 million).

Prior to joining Perella Weinberg, Ms. Al Hamoui served as Managing Director at Bank of America Merrill Lynch, where she led their Home & Personal Care practice in EMEA. Previously, she spent 10 years at Credit Suisse, where she started her career.

Ms. Al Hamoui holds a Master’s degree in Management from ESCP Business School in Paris.

Return To Team